SVA Bio-Ops began working with this U.S. based clinical-stage biopharmaceutical company upon their completed acquisition of four European biotech entities. They needed to translate the financial information of these acquired entities into a consolidated book of financial statements. They had also just completed their IPO requiring the need to report consolidated financial statements.
Finally, the company decided to make some early moves in the process of transitioning from a clinical stage company to a commercial company by upgrading from QuickBooks to a financial platform. One that would adapt to their growing business needs and sophistication as well as be flexible enough to allow for long-term growth as the business matures.